Exome Asset Management
Sameh A. has a strong background in economics and healthcare research. Sameh has worked as a Senior Investment Analyst at Exome Asset Management, conducting quantitative analysis on potential investments in biotech, med devices, and pharmaceuticals. Sameh also has experience as a Research Assistant at the University of Oklahoma Health Sciences Center, focusing on the influence of payments from pharmaceuticals on medical research. With a Bachelor's degree in Economics and Pre-Health Sciences from New York University, Sameh is currently pursuing a Master's degree in Biotechnology at The Johns Hopkins University.
This person is not in any teams
Exome Asset Management
Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare.